Oxford Immunotec to price its IPO of stock between $13.00 and $15.00

JPMorgan and Piper Jaffray are joint bookrunning managers for deal

By Devika Patel

Knoxville, Tenn., Nov. 8 - Oxford Immunotec Global plc will sell 5.36 million common shares in its initial public offering of its ordinary stock with a greenshoe of 804,000 additional shares, according to a Form S-1/A filed Friday with the Securities and Exchange Commission. The deal was announced Oct. 15.

The shares will be sold at a price expected to fall between $13.00 and $15.00 per share.

JPMorgan and Piper Jaffray are the joint bookrunning managers. Cowen and Co. and Baird are the co-managers.

Proceeds will be used to hire additional sales, marketing and customer service personnel and expand marketing programs, for research and development programs, debt repayment, working capital and other general corporate purposes.

The diagnostics company is based in Abingdon, England. The company intends to list its common stock on the Nasdaq stock exchange under the symbol "OXFD."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.